Free Trial

Amrize Ltd $AMRZ Shares Bought by Teacher Retirement System of Texas

Amrize logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Teacher Retirement System of Texas boosted its stake in Amrize by 37% to 646,894 shares (about $34.98 million), now owning roughly 0.12% of the company.
  • Amrize beat EPS estimates for the quarter ($0.62 vs. $0.59) but missed on revenue ($2.84B vs. $2.95B); the company also declared a $0.44 per-share dividend (ex-dividend April 24, payable May 4).
  • Shares trade near $56.85 with a 12-month range of $44.12–$65.94 and a market cap of $31.44 billion, while analysts hold a consensus rating of Moderate Buy and a $64.07 price target.
  • MarketBeat previews the top five stocks to own by May 1st.

Teacher Retirement System of Texas grew its stake in Amrize Ltd (NYSE:AMRZ - Free Report) by 37.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 646,894 shares of the company's stock after acquiring an additional 174,694 shares during the period. Teacher Retirement System of Texas owned about 0.12% of Amrize worth $34,984,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in AMRZ. Geode Capital Management LLC purchased a new stake in shares of Amrize in the 2nd quarter valued at approximately $265,000. M&T Bank Corp purchased a new stake in shares of Amrize in the 2nd quarter valued at approximately $205,000. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Amrize in the 2nd quarter valued at approximately $3,870,000. Gabelli Funds LLC purchased a new stake in shares of Amrize in the 2nd quarter valued at approximately $1,083,000. Finally, AXA S.A. purchased a new stake in shares of Amrize in the 2nd quarter valued at approximately $1,065,000.

Amrize Price Performance

Shares of AMRZ opened at $56.85 on Friday. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $65.94. The firm's fifty day simple moving average is $58.24 and its 200-day simple moving average is $54.56. The firm has a market capitalization of $31.44 billion and a price-to-earnings ratio of 23.11. The company has a current ratio of 1.64, a quick ratio of 1.10 and a debt-to-equity ratio of 0.37.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings data on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, beating analysts' consensus estimates of $0.59 by $0.03. The firm had revenue of $2.84 billion during the quarter, compared to analyst estimates of $2.95 billion. The business's revenue for the quarter was down .4% on a year-over-year basis. Equities analysts forecast that Amrize Ltd will post 2.76 EPS for the current fiscal year.

Amrize Announces Dividend

The business also recently disclosed a dividend, which will be paid on Monday, May 4th. Shareholders of record on Monday, April 27th will be issued a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, April 24th.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Weiss Ratings raised shares of Amrize from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, March 18th. Oppenheimer reaffirmed an "outperform" rating and set a $70.00 target price (up from $64.00) on shares of Amrize in a research note on Thursday, February 19th. Wells Fargo & Company cut their target price on shares of Amrize from $66.00 to $65.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 15th. Royal Bank Of Canada upped their target price on shares of Amrize from $60.00 to $61.00 and gave the stock a "sector perform" rating in a research note on Thursday, February 19th. Finally, Berenberg Bank set a $70.00 price target on shares of Amrize in a research note on Thursday, February 19th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $64.07.

View Our Latest Research Report on AMRZ

Insider Activity at Amrize

In related news, insider Mario Gross acquired 3,200 shares of the business's stock in a transaction on Friday, March 13th. The shares were bought at an average price of $55.29 per share, with a total value of $176,928.00. Following the completion of the acquisition, the insider owned 30,947 shares in the company, valued at $1,711,059.63. This trade represents a 11.53% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CTO Roald Brouwer acquired 2,000 shares of the business's stock in a transaction on Friday, March 13th. The shares were bought at an average cost of $54.88 per share, for a total transaction of $109,760.00. Following the acquisition, the chief technology officer owned 18,257 shares of the company's stock, valued at $1,001,944.16. This represents a 12.30% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 77,834 shares of company stock valued at $4,511,344 in the last quarter. Company insiders own 0.54% of the company's stock.

Amrize Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

See Also

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines